1	Transcription	transcription	_	_	_	_	_	_	_
2	factors	factor	_	_	_	_	_	_	_
3	as	as	_	_	_	_	_	_	_
4	targets	target	_	_	_	_	_	_	_
5	for	for	_	_	_	_	_	_	_
6	oxidative	oxidative	_	_	_	_	_	_	_
7	signalling	signalling	_	_	_	_	_	_	_
8	during	during	_	_	_	_	_	_	_
9	lymphocyte	lymphocyte	_	_	_	_	_	_	_
10	activation	activation	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	previously	previously	_	_	_	_	_	_	_
3	have	have	_	_	_	_	_	_	_
4	demonstrated	demonstrate	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	requirement	requirement	_	_	_	_	_	_	_
7	for	for	_	_	_	_	_	_	_
8	oxidative	oxidative	_	_	_	_	_	_	_
9	events	event	_	_	_	_	_	_	_
10	during	during	_	_	_	_	_	_	_
11	cell	cell	_	_	_	_	_	_	_
12	cycle	cycle	_	_	_	_	_	_	_
13	entry	entry	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	T	t	_	_	_	_	_	_	_
16	lymphocytes	lymphocyte	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	have	have	_	_	_	_	_	_	_
19	hypothesised	hypothesise	_	_	_	_	_	_	_
20	that	that	_	_	_	_	_	_	_
21	reactive	reactive	_	_	_	_	_	_	_
22	oxygen	oxygen	_	_	_	_	_	_	_
23	species	specie	_	_	_	_	_	_	_
24	may	may	_	_	_	_	_	_	_
25	act	act	_	_	_	_	_	_	_
26	as	as	_	_	_	_	_	_	_
27	intracellular	intracellular	_	_	_	_	_	_	_
28	signalling	signalling	_	_	_	_	_	_	_
29	agents	agent	_	_	_	_	_	_	_
30	during	during	_	_	_	_	_	_	_
31	lymphocyte	lymphocyte	_	_	_	_	_	_	_
32	activation	activation	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	current	current	_	_	_	_	_	_	_
4	study	study	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	cysteamine	cysteamine	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	an	an	_	_	_	_	_	_	_
9	aminothiol	aminothiol	_	_	_	_	_	_	_
10	compound	compound	_	_	_	_	_	_	_
11	with	with	_	_	_	_	_	_	_
12	antioxidant	antioxidant	_	_	_	_	_	_	_
13	activity	activity	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	has	have	_	_	_	_	_	_	_
16	been	be	_	_	_	_	_	_	_
17	used	use	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	further	further	_	_	_	_	_	_	_
20	investigate	investigate	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	role	role	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	oxidative	oxidative	_	_	_	_	_	_	_
25	signalling	signalling	_	_	_	_	_	_	_
26	during	during	_	_	_	_	_	_	_
27	lymphocyte	lymphocyte	_	_	_	_	_	_	_
28	activation	activation	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	Treatment	Treatment	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	normal	normal	_	_	_	_	_	_	_
4	human	human	_	_	_	_	_	_	_
5	peripheral	peripheral	_	_	_	_	_	_	_
6	blood	blood	_	_	_	_	_	_	_
7	lymphocytes	lymphocyte	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	cysteamine	cysteamine	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	vitro	vitro	_	_	_	_	_	_	_
12	was	be	_	_	_	_	_	_	_
13	found	find	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	inhibit	inhibit	_	_	_	_	_	_	_
16	proliferation	proliferation	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	a	a	_	_	_	_	_	_	_
19	dose-dependent	dose-dependent	_	_	_	_	_	_	_
20	manner	manner	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	with	with	_	_	_	_	_	_	_
23	essentially	essentially	_	_	_	_	_	_	_
24	complete	complete	_	_	_	_	_	_	_
25	inhibition	inhibition	_	_	_	_	_	_	_
26	occurring	occur	_	_	_	_	_	_	_
27	at	at	_	_	_	_	_	_	_
28	a	a	_	_	_	_	_	_	_
29	dose	dose	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	400	400	_	_	_	_	_	_	_
32	microM	microm	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	inhibitory	inhibitory	_	_	_	_	_	_	_
3	effect	effect	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	limited	limit	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	first	first	_	_	_	_	_	_	_
9	2	2	_	_	_	_	_	_	_
10	h	h	_	_	_	_	_	_	_
11	after	after	_	_	_	_	_	_	_
12	mitogenic	mitogenic	_	_	_	_	_	_	_
13	activation	activation	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	localizing	localize	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	time-frame	time-frame	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	action	action	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	cysteamine	cysteamine	_	_	_	_	_	_	_
22	to	to	_	_	_	_	_	_	_
23	within	within	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	commitment	commitment	_	_	_	_	_	_	_
26	period	period	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	It	it	_	_	_	_	_	_	_
2	therefore	therefore	_	_	_	_	_	_	_
3	was	be	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	interest	interest	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	establish	establish	_	_	_	_	_	_	_
8	which	which	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	if	if	_	_	_	_	_	_	_
11	any	any	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	commitment	commitment	_	_	_	_	_	_	_
14	events	event	_	_	_	_	_	_	_
15	were	be	_	_	_	_	_	_	_
16	affected	affect	_	_	_	_	_	_	_
17	by	by	_	_	_	_	_	_	_
18	oxidative	oxidative	_	_	_	_	_	_	_
19	signalling	signalling	_	_	_	_	_	_	_
20	during	during	_	_	_	_	_	_	_
21	cell	cell	_	_	_	_	_	_	_
22	cycle	cycle	_	_	_	_	_	_	_
23	entry	entry	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Taking	take	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	IL-2	il-2	_	_	_	_	_	_	_
4	gene	gene	_	_	_	_	_	_	_
5	as	as	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	candidate	candidate	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	we	we	_	_	_	_	_	_	_
10	examined	examine	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	effect	effect	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	cysteamine	cysteamine	_	_	_	_	_	_	_
15	treatment	treatment	_	_	_	_	_	_	_
16	on	on	_	_	_	_	_	_	_
17	early	early	_	_	_	_	_	_	_
18	gene	gene	_	_	_	_	_	_	_
19	expression	expression	_	_	_	_	_	_	_
20	during	during	_	_	_	_	_	_	_
21	lymphocyte	lymphocyte	_	_	_	_	_	_	_
22	activation	activation	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	on	on	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	activity	activity	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	transcription	transcription	_	_	_	_	_	_	_
30	factors	factor	_	_	_	_	_	_	_
31	AP-1	ap-1	_	_	_	_	_	_	_
32	,	,	_	_	_	_	_	_	_
33	NF-kappa	NF-kappa	_	_	_	_	_	_	_
34	B	B	_	_	_	_	_	_	_
35	,	,	_	_	_	_	_	_	_
36	NF-AT	NF-AT	_	_	_	_	_	_	_
37	and	and	_	_	_	_	_	_	_
38	Oct1	Oct1	_	_	_	_	_	_	_
39	,	,	_	_	_	_	_	_	_
40	whose	whose	_	_	_	_	_	_	_
41	functions	function	_	_	_	_	_	_	_
42	are	be	_	_	_	_	_	_	_
43	required	require	_	_	_	_	_	_	_
44	for	for	_	_	_	_	_	_	_
45	expression	expression	_	_	_	_	_	_	_
46	of	of	_	_	_	_	_	_	_
47	the	the	_	_	_	_	_	_	_
48	IL-2	il-2	_	_	_	_	_	_	_
49	mRNA	mrna	_	_	_	_	_	_	_
50	.	.	_	_	_	_	_	_	_

1	Cysteamine	Cysteamine	_	_	_	_	_	_	_
2	treatment	treatment	_	_	_	_	_	_	_
3	inhibited	inhibit	_	_	_	_	_	_	_
4	both	both	_	_	_	_	_	_	_
5	expression	expression	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	IL-2	il-2	_	_	_	_	_	_	_
9	mRNA	mrna	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	secretion	secretion	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	IL-2	il-2	_	_	_	_	_	_	_
14	into	into	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	culture	culture	_	_	_	_	_	_	_
17	medium	medium	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	inhibitory	inhibitory	_	_	_	_	_	_	_
3	effect	effect	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	cysteamine	cysteamine	_	_	_	_	_	_	_
6	may	may	_	_	_	_	_	_	_
7	be	be	_	_	_	_	_	_	_
8	mediated	mediate	_	_	_	_	_	_	_
9	at	at	_	_	_	_	_	_	_
10	least	least	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	part	part	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	an	an	_	_	_	_	_	_	_
15	effect	effect	_	_	_	_	_	_	_
16	on	on	_	_	_	_	_	_	_
17	transcription	transcription	_	_	_	_	_	_	_
18	factor	factor	_	_	_	_	_	_	_
19	function	function	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	as	as	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	DNA	dna	_	_	_	_	_	_	_
24	binding	binding	_	_	_	_	_	_	_
25	activities	activity	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	AP-1	AP-1	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	NF-kappa	NF-kappa	_	_	_	_	_	_	_
30	B	B	_	_	_	_	_	_	_
31	extracted	extract	_	_	_	_	_	_	_
32	from	from	_	_	_	_	_	_	_
33	mitogen-stimulated	mitogen-stimulated	_	_	_	_	_	_	_
34	cells	cell	_	_	_	_	_	_	_
35	were	be	_	_	_	_	_	_	_
36	significantly	significantly	_	_	_	_	_	_	_
37	inhibited	inhibit	_	_	_	_	_	_	_
38	by	by	_	_	_	_	_	_	_
39	cysteamine	cysteamine	_	_	_	_	_	_	_
40	treatment	treatment	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

1	Interestingly	interestingly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	Oct1	Oct1	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	NF-AT	NF-AT	_	_	_	_	_	_	_
6	DNA	DNA	_	_	_	_	_	_	_
7	binding	binding	_	_	_	_	_	_	_
8	activity	activity	_	_	_	_	_	_	_
9	were	be	_	_	_	_	_	_	_
10	not	not	_	_	_	_	_	_	_
11	affected	affect	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	cysteamine	cysteamine	_	_	_	_	_	_	_
14	treatment	treatment	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	suggesting	suggest	_	_	_	_	_	_	_
17	that	that	_	_	_	_	_	_	_
18	oxidative	oxidative	_	_	_	_	_	_	_
19	signalling	signalling	_	_	_	_	_	_	_
20	processes	process	_	_	_	_	_	_	_
21	operate	operate	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	a	a	_	_	_	_	_	_	_
24	selective	selective	_	_	_	_	_	_	_
25	manner	manner	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	identification	identification	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	regulatory	regulatory	_	_	_	_	_	_	_
5	proteins	protein	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	such	such	_	_	_	_	_	_	_
8	as	as	_	_	_	_	_	_	_
9	transcription	transcription	_	_	_	_	_	_	_
10	factors	factor	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	as	as	_	_	_	_	_	_	_
13	molecular	molecular	_	_	_	_	_	_	_
14	targets	target	_	_	_	_	_	_	_
15	for	for	_	_	_	_	_	_	_
16	oxidative	oxidative	_	_	_	_	_	_	_
17	signalling	signalling	_	_	_	_	_	_	_
18	provides	provide	_	_	_	_	_	_	_
19	further	further	_	_	_	_	_	_	_
20	evidence	evidence	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	implicate	implicate	_	_	_	_	_	_	_
23	oxidative	oxidative	_	_	_	_	_	_	_
24	signalling	signalling	_	_	_	_	_	_	_
25	as	as	_	_	_	_	_	_	_
26	being	be	_	_	_	_	_	_	_
27	intimately	intimately	_	_	_	_	_	_	_
28	involved	involve	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	G0	g0	_	_	_	_	_	_	_
32	to	to	_	_	_	_	_	_	_
33	G1	g1	_	_	_	_	_	_	_
34	phase	phase	_	_	_	_	_	_	_
35	transition	transition	_	_	_	_	_	_	_
36	in	in	_	_	_	_	_	_	_
37	T	t	_	_	_	_	_	_	_
38	lymphocytes	lymphocyte	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

